Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Field Performance of Two Methods for Detection of Poliovirus in Wastewater Samples, Mexico 2016-2017.

Estívariz CF, Pérez-Sánchez EE, Bahena A, Burns CC, Gary HE Jr, García-Lozano H, Rey-Benito G, Peñaranda S, Castillo-Montufar KV, Nava-Acosta RS, Meschke JS, Oberste MS, Lopez-Martínez I, Díaz-Quiñonez JA.

Food Environ Virol. 2019 Sep 30. doi: 10.1007/s12560-019-09399-9. [Epub ahead of print]

PMID:
31571037
2.

High-Dimensional Single-Cell Cartography Reveals Novel Skeletal Muscle-Resident Cell Populations.

Giordani L, He GJ, Negroni E, Sakai H, Law JYC, Siu MM, Wan R, Corneau A, Tajbakhsh S, Cheung TH, Le Grand F.

Mol Cell. 2019 May 2;74(3):609-621.e6. doi: 10.1016/j.molcel.2019.02.026. Epub 2019 Mar 25.

PMID:
30922843
3.

Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.

Zaman K, Estívariz CF, Morales M, Yunus M, Snider CJ, Gary HE Jr, Weldon WC, Oberste MS, Wassilak SG, Pallansch MA, Anand A.

Lancet Infect Dis. 2018 Jun;18(6):657-665. doi: 10.1016/S1473-3099(18)30113-0. Epub 2018 Mar 20.

PMID:
29571817
4.

Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.

White JA, Estrada M, Weldon WC, Chumakov K, Kouiavskaia D, Fournier-Caruana J, Stevens E, Gary HE Jr, Maes EF, Oberste MS, Snider CJ, Anand A, Chen D.

Biologicals. 2018 May;53:30-38. doi: 10.1016/j.biologicals.2018.03.002. Epub 2018 Mar 14.

5.

Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, Marin M, Riley J, Feikin DR, Patel M, Quinlisk P.

N Engl J Med. 2017 Sep 7;377(10):947-956. doi: 10.1056/NEJMoa1703309.

6.

The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.

Cowger TL, Burns CC, Sharif S, Gary HE Jr, Iber J, Henderson E, Malik F, Zahoor Zaidi SS, Shaukat S, Rehman L, Pallansch MA, Orenstein WA.

PLoS One. 2017 Jul 25;12(7):e0180608. doi: 10.1371/journal.pone.0180608. eCollection 2017.

7.

Pathogen-Specific Burden of Outpatient Diarrhea in Infants in Nepal: A Multisite Prospective Case-Control Study.

Cardemil CV, Sherchand JB, Shrestha L, Sharma A, Gary HE, Estivariz CF, Diez-Valcarce M, Ward ML, Bowen MD, Vinjé J, Parashar U, Chu SY.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e75-e85. doi: 10.1093/jpids/pix009.

PMID:
28472489
8.

Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010.

Cardemil CV, Jonas A, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:189-95. doi: 10.1016/j.ijid.2016.05.020. Epub 2016 May 24.

9.

Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010.

Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:196-201. doi: 10.1016/j.ijid.2016.05.009. Epub 2016 May 16.

10.

The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal.

Cardemil CV, Estivariz C, Shrestha L, Sherchand JB, Sharma A, Gary HE Jr, Oberste MS, Weldon WC 3rd, Bowen MD, Vinjé J, Schluter WW, Anand A, Mach O, Chu SY.

Vaccine. 2016 May 11;34(22):2519-26. doi: 10.1016/j.vaccine.2016.03.027. Epub 2016 Apr 13.

PMID:
27085172
11.

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.

Anand A, Zaman K, Estívariz CF, Yunus M, Gary HE, Weldon WC, Bari TI, Steven Oberste M, Wassilak SG, Luby SP, Heffelfinger JD, Pallansch MA.

Vaccine. 2015 Nov 27;33(48):6816-22. doi: 10.1016/j.vaccine.2015.09.039. Epub 2015 Oct 23.

PMID:
26476367
12.

Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial.

Estívariz CF, Anand A, Gary HE Jr, Rahman M, Islam J, Bari TI, Wassilak SG, Chu SY, Weldon WC, Pallansch MA, Heffelfinger JD, Luby SP, Zaman K.

Lancet Infect Dis. 2015 Aug;15(8):898-904. doi: 10.1016/S1473-3099(15)00094-8. Epub 2015 Jun 17.

PMID:
26093980
13.

Effect of time at temperature on wild poliovirus titers in stool specimens.

Walker AT, Williams AJ, Gary HE Jr, Pallansch MA, Wassilak SG, Oberste MS.

Virology. 2015 Aug;482:28-31. doi: 10.1016/j.virol.2015.03.005. Epub 2015 Mar 30.

14.

An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India.

Bahl S, Gary HE Jr, Jafari H, Sarkar BK, Pathyarch SK, Sethi R, Deshpande J.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S234-42. doi: 10.1093/infdis/jiu379.

PMID:
25316841
15.

Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh.

Deshpande JM, Bahl S, Sarkar BK, Estívariz CF, Sharma S, Wolff C, Sethi R, Pathyarch SK, Jain V, Gary HE Jr, Pallansch MA, Jafari H.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S225-33. doi: 10.1093/infdis/jiu204.

PMID:
25316839
16.

Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects.

Luo X, Chen J, Song WX, Tang N, Luo J, Deng ZL, Sharff KA, He G, Bi Y, He BC, Bennett E, Huang J, Kang Q, Jiang W, Su Y, Zhu GH, Yin H, He Y, Wang Y, Souris JS, Chen L, Zuo GW, Montag AG, Reid RR, Haydon RC, Luu HH, He TC.

Lab Invest. 2008 Dec;88(12):1264-77. doi: 10.1038/labinvest.2008.98. Epub 2008 Oct 6.

17.

The risks, costs, and benefits of possible future global policies for managing polioviruses.

Thompson KM, Tebbens RJ, Pallansch MA, Kew OM, Sutter RW, Aylward RB, Watkins M, Gary HE Jr, Alexander J, Jafari H, Cochi SL.

Am J Public Health. 2008 Jul;98(7):1322-30. doi: 10.2105/AJPH.2007.122192. Epub 2008 May 29.

18.

Failure to detect infection by oral polio vaccine virus following natural exposure among inactivated polio vaccine recipients.

Gary HE Jr, Smith B, Jenks J, Ruiz J, Sessions W, Vinje J, Sobsey M.

Epidemiol Infect. 2008 Feb;136(2):180-3. Epub 2007 Mar 22.

19.

Morphological characterization of the breast in Proteus syndrome complicated by ductal carcinoma in situ.

Iqbal J, He G, Biesecker LG, Rosen P, Duray PH, Schwartzentruber D, Beg M, Kahn E.

Ann Clin Lab Sci. 2006 Autumn;36(4):469-74.

PMID:
17127737
20.

Environmental surveillance of wild poliovirus circulation in Egypt--balancing between detection sensitivity and workload.

Hovi T, Blomqvist S, Nasr E, Burns CC, Sarjakoski T, Ahmed N, Savolainen C, Roivainen M, Stenvik M, Laine P, Barakat I, Wahdan MH, Kamel FA, Asghar H, Pallansch MA, Kew OM, Gary HE Jr, deGourville EM, El Bassioni L.

J Virol Methods. 2005 Jun;126(1-2):127-34.

PMID:
15847928
21.

Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola.

Vinjé J, Gregoricus N, Martin J, Gary HE Jr, Caceres VM, Venczel L, Macadam A, Dobbins JG, Burns C, Wait D, Ko G, Landaverde M, Kew O, Sobsey MD.

J Infect Dis. 2004 Apr 1;189(7):1168-75. Epub 2004 Mar 16.

PMID:
15031784
22.

Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba.

Más Lago P, Gary HE Jr, Pérez LS, Cáceres V, Olivera JB, Puentes RP, Corredor MB, Jímenez P, Pallansch MA, Cruz RG.

Int J Epidemiol. 2003 Oct;32(5):772-7.

PMID:
14559748
23.

Contribution of second stool specimen to increased sensitivity of poliovirus detection in India, 1998-2000.

Kohler KA, Deshpande JM, Gary HE Jr, Banerjee K, Zuber PL, Hlady WG.

Epidemiol Infect. 2003 Aug;131(1):711-8.

24.

Can post-eradication laboratory containment of wild polioviruses be achieved?

Dowdle WR, Gary HE, Sanders R, van Loon AM.

Bull World Health Organ. 2002;80(4):311-6.

25.

Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication.

Más Lago P, Cáceres VM, Galindo MA, Gary HE Jr, Valcarcel M, Barrios J, Sarmiento L, Avalos I, Bravo JA, Palomera R, Bello M, Sutter RW, Pallansch MA, de Quadros CA.

Int J Epidemiol. 2001 Oct;30(5):1029-34.

PMID:
11689516
26.

Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia.

Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, Othman G, Radzi HM, Kitsutani PT, Stockton PC, Arokiasamy J, Gary HE Jr, Anderson LJ.

J Infect Dis. 2000 May;181(5):1755-9. Epub 2000 May 15.

PMID:
10823779
27.

The effect of timing of sample collection on the detection of measles-specific IgM in serum and oral fluid samples after primary measles vaccination.

Helfand RF, Kebede S, Mercader S, Gary HE Jr, Beyene H, Bellini WJ.

Epidemiol Infect. 1999 Dec;123(3):451-5.

28.

Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.

Marx A, Gary HE Jr, Marston BJ, Erdman DD, Breiman RF, Török TJ, Plouffe JF, File TM Jr, Anderson LJ.

Clin Infect Dis. 1999 Jul;29(1):134-40.

PMID:
10433576
29.

Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination.

Helfand RF, Kebede S, Gary HE Jr, Beyene H, Bellini WJ.

Clin Diagn Lab Immunol. 1999 Mar;6(2):178-80.

30.

Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.

Han LL, Popovici F, Alexander JP Jr, Laurentia V, Tengelsen LA, Cernescu C, Gary HE Jr, Ion-Nedelcu N, Campbell GL, Tsai TF.

J Infect Dis. 1999 Jan;179(1):230-3.

PMID:
9841844
31.

Nonclassic measles infections in an immune population exposed to measles during a college bus trip.

Helfand RF, Kim DK, Gary HE Jr, Edwards GL, Bisson GP, Papania MJ, Heath JL, Schaff DL, Bellini WJ, Redd SC, Anderson LJ.

J Med Virol. 1998 Dec;56(4):337-41.

PMID:
9829639
32.

Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination.

Helfand RF, Gary HE Jr, Atkinson WL, Nordin JD, Keyserling HL, Bellini WJ.

Clin Diagn Lab Immunol. 1998 Mar;5(2):135-8.

33.

Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993.

Reyes M, Gary HE Jr, Dobbins JG, Randall B, Steele L, Fukuda K, Holmes GP, Connell DG, Mawle AC, Schmid DS, Stewart JA, Schonberger LB, Gunn WJ, Reeves WC.

MMWR CDC Surveill Summ. 1997 Feb 21;46(2):1-13.

34.

Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine.

Gary HE Jr, Freeman C, Peñaranda S, Maher K, Anderson L, Pallansch MA.

J Infect Dis. 1997 Feb;175 Suppl 1:S264-7.

PMID:
9203727
35.

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.

Alexander JP Jr, Gary HE Jr, Pallansch MA.

J Infect Dis. 1997 Feb;175 Suppl 1:S176-82. Review.

PMID:
9203713
39.

Immune responses associated with chronic fatigue syndrome: a case-control study.

Mawle AC, Nisenbaum R, Dobbins JG, Gary HE Jr, Stewart JA, Reyes M, Steele L, Schmid DS, Reeves WC.

J Infect Dis. 1997 Jan;175(1):136-41.

PMID:
8985207
40.

Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile.

Dowell SF, Papic Z, Bresee JS, Larrañaga C, Mendez M, Sowell AL, Gary HE Jr, Anderson LJ, Avendaño LF.

Pediatr Infect Dis J. 1996 Sep;15(9):782-6.

PMID:
8878221
41.

Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States.

Bresee JS, Fischer M, Dowell SF, Johnston BD, Biggs VM, Levine RS, Lingappa JR, Keyserling HL, Petersen KM, Bak JR, Gary HE Jr, Sowell AL, Rubens CE, Anderson LJ.

Pediatr Infect Dis J. 1996 Sep;15(9):777-82.

PMID:
8878220
42.

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.

Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, Marston BJ, Breiman RF.

J Infect Dis. 1996 Sep;174(3):456-62.

PMID:
8769600
43.

Outbreak of vertigo in Wyoming: possible role of an enterovirus infection.

Simonsen L, Khan AS, Gary HE Jr, Hanson C, Pallansch MA, Music S, Holman RC, Stewart JA, Erdman DD, Arden NH, Arenberg IK, Schonberger LB.

Epidemiol Infect. 1996 Aug;117(1):149-57.

44.

Comparative detection of measles-specific IgM in oral fluid and serum from children by an antibody-capture IgM EIA.

Helfand RF, Kebede S, Alexander JP Jr, Alemu W, Heath JL, Gary HE Jr, Anderson LJ, Beyene H, Bellini WJ.

J Infect Dis. 1996 Jun;173(6):1470-4.

PMID:
8648222
45.

A university outbreak of gastroenteritis due to a small round-structured virus. Application of molecular diagnostics to identify the etiologic agent and patterns of transmission.

Kilgore PE, Belay ED, Hamlin DM, Noel JS, Humphrey CD, Gary HE Jr, Ando T, Monroe SS, Kludt PE, Rosenthal DS, Freeman J, Glass RI.

J Infect Dis. 1996 Apr;173(4):787-93.

PMID:
8603955
46.

Seroepidemiology of chronic fatigue syndrome: a case-control study.

Mawle AC, Nisenbaum R, Dobbins JG, Gary HE Jr, Stewart JA, Reyes M, Steele L, Schmid DS, Reeves WC.

Clin Infect Dis. 1995 Dec;21(6):1386-9.

PMID:
8749620
47.

Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group.

Helfand RF, Gary HE Jr, Freeman CY, Anderson LJ, Pallansch MA.

J Infect Dis. 1995 Nov;172(5):1206-11.

PMID:
7594655
48.

National surveillance for respiratory syncytial virus, United States, 1985-1990.

Gilchrist S, Török TJ, Gary HE Jr, Alexander JP, Anderson LJ.

J Infect Dis. 1994 Oct;170(4):986-90.

PMID:
7930745
49.

Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer.

Reeves WC, Gary HE Jr, Johnson PR, Icenogle JP, Brenes MM, de Britton RM, Dobbins JG, Schmid DS.

J Infect Dis. 1994 Oct;170(4):753-8.

PMID:
7930714
50.

A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women.

Vernon SD, Reeves WC, Clancy KA, Laga M, St Louis M, Gary HE Jr, Ryder RW, Manoka AT, Icenogle JP.

J Infect Dis. 1994 May;169(5):1108-12.

PMID:
8169402

Supplemental Content

Loading ...
Support Center